Omzet 2024 * | 2,72 mld. 10,35 mld. 2,56 mld. | Omzet 2025 * | 3,05 mld. 11,6 mld. 2,87 mld. | Marktkapitalisatie | 14,64 mld. 55,64 mld. 13,76 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 439 mln. 1,67 mld. 413 mln. | Nettowinst (verlies) 2025 * | 528 mln. 2,01 mld. 496 mln. | EV/omzet 2024 * | 4,89 x |
Nettoliquiditeiten 2024 * | 1,32 mld. 5 mld. 1,24 mld. | Nettoliquiditeiten 2025 * | 2,15 mld. 8,18 mld. 2,02 mld. | EV/omzet 2025 * | 4,09 x |
K/w-verhouding 2024 * |
35,4
x | K/w-verhouding 2025 * |
29,2
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 84,08% |
Recentste transcriptie over NICE Ltd.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Barak Eilam
CEO | Chief Executive Officer | 49 | 30-04-14 |
Darren Rushworth
PSD | President | 56 | 01-01-17 |
Mary Gaspich
DFI | Director of Finance/CFO | 59 | 01-10-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Léo Apotheker
BRD | Director/Board Member | 69 | 01-08-13 |
David Kostman
CHM | Chairman | 59 | 01-01-01 |
Dan Falk
BRD | Director/Board Member | 79 | 01-01-01 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,52% | 3.060 mld. | |
+0,93% | 80,48 mld. | |
+4,97% | 80,07 mld. | |
-13,12% | 53,61 mld. | |
-18,60% | 50,6 mld. | |
+23,06% | 47,15 mld. | |
+12,30% | 39,16 mld. | |
+39,01% | 31,53 mld. | |
-12,62% | 24,42 mld. |